Research
Energy balance
Tirzepatide has been approved by the FDA for treating T2D and managing chronic weight in overweight or obese patients.
Healthcare providers can confidently prescribe tirzepatide for eligible patients based on FDA approval.
StrongSupportsmedium confidence
Therefore, it has been approved by the Food and Drug Administration (FDA) for treating T2D and managing chronic weight in overweight or obese patients.
Why this rating
FDA approval is a strong indicator of efficacy and safety.
Source
Tirzepatide in Treating Metabolic Disorders
Shulin Wei et al. · International Journal of Drug Discovery and Pharmacology · 2024
reviewCited 3×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →